KZR vs SBUX · $53.9M cap vs P/E 76, rev $37.18B
Kezar Life Sciences Inc (KZR) versus Starbucks Corporation (SBUX) — a side-by-side from cached financials, not a winner call.
Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.
Starbucks Corporation (SBUX) is a restaurants company listed on NASDAQ. It is led by Brian R. Niccol.
Latest reported KZR revenue for 2024-12-31 was $0. Net income was -$83.7M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. KZR currently screens at market cap $53.9M.
Latest reported SBUX revenue for 2025-09-28 was $37.18B. Net income was $1.86B. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
KZR currently screens at market cap $53.9M. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
Not investment advice. Open the KZR and SBUX stock pages for the full models.
Not investment advice.